PROK ProKidney Corp. - Class A Ordinary Shares
$1.59
Price · May 20, 2026
Fundamentals as of May 15, 2026
52W Range
$1–$7
16% of range
Analyst Rating
STRONG BUY
15 analysts
Price Target
$6
+294% upside
P/E (TTM)
—
ROE
6.9%
Net Profit Margin
-7725.2%
PROK Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$1.58
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
$893.0K
Div Yield
—
ROE
6.9%
Debt/Equity
—
52W Range
$1 – $7
PROK Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
$893.0K
2022-12-31
→
2025-12-31
EPS
—
2022-12-31
→
2022-12-31
Free Cash Flow
$-135M
2023-12-31
→
2025-12-31
Margins
-7725.2%
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
PROK
Peer Median
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
PROK
Peer Median
Operating Margin
-18477.8%
—
Net Profit Margin
-7725.2%
-240.1%
ROA
-17.8%
-25.8%
ROE
6.9%
-29.9%
ROIC
16.4%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
PROK
Peer Median
Current Ratio
9.1
9.1
Quick Ratio
3.5
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
PROK
Peer Median
Revenue YoY
1075.0%
—
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
PROK
Peer Median
PROK Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
15 analysts
- Strong Buy 5 33.3%
- Buy 5 33.3%
- Hold 4 26.7%
- Sell 1 6.7%
- Strong Sell 0 0.0%
12-Month Price Target
6 analysts · 2026-05-17
Median
$5.75
Now
$1.58
Low
$1.00
High
$12.00
Median target
$5.75
+262.8%
Mean target
$6.25
+294.3%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
0.00%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-0.14 | $-0.14 | 0.00% |
| Dec. 31, 2025 | $-0.14 | $-0.12 | -0.02% |
| Sept. 30, 2025 | $-0.12 | $-0.13 | 0.01% |
| June 30, 2025 | $-0.13 | $-0.15 | 0.02% |
| March 31, 2025 | $-0.13 | $-0.16 | 0.03% |
| Dec. 31, 2024 | $-0.17 | $-0.15 | -0.02% |
Peer Comparison Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| PROK | — | — | 1075.0% | -7725.2% | 6.9% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| XOMA | $315M | 18.2 | 83.1% | 60.8% | 43.5% | — |
| STRO | $99M | -0.5 | 65.2% | -186.5% | 232.2% | — |
| PRME | $626M | -2.6 | 55.3% | -4342.4% | -221.4% | — |
| IMMX | $277M | -5.9 | — | — | -59.8% | — |
| ACHV | — | -4.0 | — | — | — | — |
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $893.0K | $76.0K | $0 | $0 | |
| R&D Expense | $114M | $128M | $107M | $82M | |
| SG&A Expense | $52M | $56M | $45M | $71M | |
| Operating Expenses | $166M | $184M | $152M | $153M | |
| Operating Income | $-165M | $-184M | $-152M | $-153M | |
| Interest Expense | $4.0K | $9.0K | $12.0K | $215.0K | |
| Pretax Income | $-151M | $-164M | $-129M | $-147M | |
| Income Tax | $414.0K | $-598.0K | $6M | $896.0K | |
| Net Income | $-69M | $-61M | $-35M | · | |
| EPS (Basic) | · | · | · | $-0.23 | |
| EPS (Diluted) | · | · | · | $-0.23 | |
| Shares (Basic) | · | · | · | 61,540,231 | |
| Shares (Diluted) | · | · | · | 61,540,231 | |
| EBITDA | $-158M | $-178M | $-148M | · |
Balance Sheet 17
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $109M | $99M | $61M | $490M | |
| Other Current Assets | $3M | $80.0K | $9.0K | $1M | |
| Current Assets | $281M | $396M | $374M | $505M | |
| PP&E (Net) | $51M | $42M | $42M | $11M | |
| Accum. Depreciation | $17M | $11M | $8M | $5M | |
| Intangibles | · | · | $0 | $213.0K | |
| Total Assets | $336M | $441M | $421M | $518M | |
| Accounts Payable | $940.0K | $4M | $5M | $3M | |
| Accrued Liabilities | $29M | $31M | $18M | $7M | |
| Current Liabilities | $31M | $36M | $25M | $11M | |
| Capital Leases | $3M | $2M | $4M | $2M | |
| Total Liabilities | $35M | $39M | $29M | $13M | |
| Paid-in Capital | $259M | $206M | $36M | $7M | |
| Retained Earnings | $-1.27B | $-1.20B | $-1.14B | $-1.10B | |
| AOCI | $56.0K | $130.0K | $130.0K | $0 | |
| Stockholders' Equity | $-1.01B | $-995M | $-1.10B | $-1.10B | |
| Liabilities + Equity | $336M | $441M | $421M | $518M |
Cash Flow 15
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | $7M | $5M | $4M | $3M | |
| Stock-based Comp | $25M | $29M | $31M | $74M | |
| Amort. of Intangibles | $0 | $0 | $213.0K | $215.0K | |
| Other Non-cash | $-83M | $-100M | $-89M | · | |
| Operating Cash Flow | $-120M | $-126M | $-90M | $-77M | |
| CapEx | $15M | $30M | $34M | $2M | |
| Investing Cash Flow | $104M | $20M | $-330M | $-2M | |
| Stock Issued | $24M | $144M | $0 | $0 | |
| Stock Repurchased | $0 | $0 | $9M | $0 | |
| Net Stock Activity | $24M | $144M | $-9M | · | |
| Financing Cash Flow | $26M | $144M | $-10M | $549M | |
| Net Change in Cash | $9M | $38M | $-430M | $470M | |
| Taxes Paid | $2M | $73.0K | $3M | $2M | |
| Free Cash Flow | $-135M | $-156M | $-124M | · | |
| Levered FCF | $-135M | $-156M | $-124M | · |
Profitability 7
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -18477.8% | -241678.9% | · | · | |
| Net Margin | -7725.2% | -80507.9% | · | · | |
| Pretax Margin | -16931.5% | -215701.3% | · | · | |
| EBITDA Margin | -17741.5% | -234531.6% | · | · | |
| ROA | -17.8% | -14.2% | -7.6% | · | |
| ROE | 6.9% | 6.2% | 3.2% | · | |
| ROIC | 16.4% | 18.4% | 14.4% | · |
Liquidity & Solvency 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 9.1 | 10.9 | 14.9 | · | |
| Quick Ratio | 3.5 | 2.7 | 2.4 | · | |
| Interest Coverage | -41251.8 | -20408.4 | -12626.8 | · |
Efficiency 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | · |
Growth Rates 1
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 1075.0% | · | · | · |
Valuation (TTM) 4
| Metric | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $893.0K | $76.0K | $0 | $0 | |
| Net Income TTM | $-69M | $-61M | $-35M | $-100M | |
| P/E | · | · | · | -29.8 | |
| Earnings Yield | · | · | · | -3.4% |
Income Statement 10
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $226.0K | $225.0K | $217.0K | $221.0K | $230.0K | $76.0K | $0 | $0 | $0 | |
| R&D Expense | $34M | $34M | $27M | $26M | $27M | $40M | $31M | $29M | $27M | |
| SG&A Expense | $11M | $11M | $12M | $14M | $14M | $12M | $18M | $14M | $13M | |
| Operating Expenses | $45M | $46M | $39M | $40M | $42M | $52M | $49M | $43M | $40M | |
| Operating Income | $-45M | $-45M | $-39M | $-40M | $-41M | $-52M | $-49M | $-43M | $-40M | |
| Interest Expense | $15.0K | $1.0K | $2.0K | $1.0K | $0 | $2.0K | $2.0K | $3.0K | $2.0K | |
| Pretax Income | $-43M | $-42M | $-35M | $-36M | $-37M | $-47M | $-43M | $-39M | $-35M | |
| Income Tax | $0 | $-2M | $560.0K | $848.0K | $591.0K | $2M | $-2M | $-56.0K | $98.0K | |
| Net Income | $-20M | $-19M | $-16M | $-17M | $-17M | $-21M | $-18M | $-13M | $-9M | |
| EBITDA | $-43M | · | $-39M | $-40M | $-40M | · | $-49M | $-43M | $-39M |
Balance Sheet 16
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $102M | $109M | $95M | $85M | $98M | $99M | $108M | $215M | $84M | |
| Other Current Assets | $2M | $3M | $110.0K | $546.0K | $62.0K | $80.0K | $1M | $0 | $0 | |
| Current Assets | $235M | $281M | $300M | $324M | $360M | $396M | $430M | $450M | $340M | |
| PP&E (Net) | $54M | $51M | $48M | $44M | $43M | $42M | $39M | $43M | $42M | |
| Accum. Depreciation | $18M | $17M | $15M | $14M | $12M | $11M | $11M | $9M | $8M | |
| Total Assets | $293M | $336M | $352M | $372M | $406M | $441M | $475M | $499M | $388M | |
| Accounts Payable | $3M | $940.0K | $2M | $2M | $3M | $4M | $3M | $3M | $3M | |
| Accrued Liabilities | $22M | $29M | $26M | $25M | $28M | $31M | $21M | $15M | $13M | |
| Current Liabilities | $26M | $31M | $29M | $28M | $33M | $36M | $25M | $21M | $19M | |
| Capital Leases | $3M | $3M | $3M | $3M | $2M | $2M | $5M | $6M | $5M | |
| Total Liabilities | $30M | $35M | $33M | $33M | $36M | $39M | $31M | $27M | $25M | |
| Paid-in Capital | $266M | $259M | $242M | $232M | $219M | $206M | $200M | $189M | $53M | |
| Retained Earnings | $-1.29B | $-1.27B | $-1.25B | $-1.23B | $-1.22B | $-1.20B | $-1.18B | $-1.16B | $-1.15B | |
| AOCI | $-53.0K | $56.0K | $74.0K | $30.0K | $75.0K | $130.0K | $321.0K | $-6.0K | $-44.0K | |
| Stockholders' Equity | $-1.02B | $-1.01B | $-1.01B | $-1.00B | $-999M | $-995M | $-980M | $-972M | $-1.10B | |
| Liabilities + Equity | $293M | $336M | $352M | $372M | $406M | $441M | $475M | $499M | $388M |
Cash Flow 12
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $1M | $2M | $2M | $1M | $1M | $1M | |
| Stock-based Comp | $5M | $6M | $7M | $7M | $6M | $7M | $7M | $8M | $8M | |
| Other Non-cash | $-28M | · | · | · | $-21M | · | · | · | $-34M | |
| Operating Cash Flow | $-42M | $-33M | $-27M | $-31M | $-30M | $-24M | $-29M | $-38M | $-35M | |
| CapEx | $4M | $6M | $5M | $3M | $1M | $26M | $2M | $636.0K | $960.0K | |
| Investing Cash Flow | $35M | $28M | $29M | $19M | $28M | $15M | $-82M | $29M | $58M | |
| Stock Issued | $7.0K | $17M | $7M | · | · | $-3.0K | $4M | · | · | |
| Net Stock Activity | $7.0K | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $215.0K | $18M | $8M | $-14.0K | $-12.0K | $123.0K | $4M | $140M | $-13.0K | |
| Net Change in Cash | $-7M | $13M | $10M | $-13M | $-1M | $-9M | $-106M | $130M | $24M | |
| Free Cash Flow | $-45M | · | · | · | $-31M | · | · | · | $-36M | |
| Levered FCF | $-45M | · | · | · | $-31M | · | · | · | $-36M |
Profitability 7
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -19881.9% | · | -17759.9% | -17967.9% | -17994.8% | · | · | · | · | |
| Net Margin | -8865.9% | · | -7589.4% | -7489.6% | -7275.7% | · | · | · | · | |
| Pretax Margin | -18858.9% | · | -16259.5% | -16342.5% | -16243.9% | · | · | · | · | |
| EBITDA Margin | -19148.2% | · | -17759.9% | -17967.9% | -17299.1% | · | · | · | · | |
| ROA | -5.7% | · | -4.0% | -3.8% | -4.2% | · | -3.9% | -2.5% | -2.1% | |
| ROE | 2.0% | · | 1.7% | 1.7% | 1.6% | · | 1.7% | 1.1% | 0.70% | |
| ROIC | 4.4% | · | 3.9% | 4.0% | 4.2% | · | 4.7% | 4.4% | 3.7% |
Liquidity & Solvency 3
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.1 | · | 10.3 | 11.5 | 11.0 | · | 17.1 | 21.9 | 17.6 | |
| Quick Ratio | 3.9 | · | 3.3 | 3.0 | 3.0 | · | 4.3 | 10.4 | 4.4 | |
| Interest Coverage | -2995.5 | · | -19269.5 | -39709.0 | · | · | -24486.5 | -14352.0 | -20038.0 |
Efficiency 1
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | · |
Valuation (TTM) 2
| Metric | Trend | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $894.0K | · | $668.0K | $451.0K | $230.0K | · | · | · | · | |
| Net Income TTM | $-70M | · | $-68M | $-64M | $-57M | · | $-51M | $-42M | $-39M |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenue | $893.0K | $76.0K | $0 | $0 | — |
| Operating Margin % | -18477.8% | -241678.9% | — | — | — |
| Net Income | $-69M | $-61M | $-35M | — | $-55M |
| Diluted EPS | — | — | — | $-0.23 | — |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Current Ratio | 9.1 | 10.9 | 14.9 | — | 0.5 |
| Quick Ratio | 3.5 | 2.7 | 2.4 | — | 0.2 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | $-135M | $-156M | $-124M | — | — |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.